Copine 1 inhibitors represent a class of compounds designed to modulate the activity of copine 1, a calcium-dependent phospholipid-binding protein that plays a crucial role in various cellular processes. Copines, as a family of proteins, are recognized for their involvement in cellular signaling, membrane dynamics, and cytoskeletal organization. Copine 1, in particular, is predominantly expressed in neuronal tissues, suggesting its significance in the nervous system. The inhibitors targeting copine 1 are designed to selectively interact with the protein, impeding its normal function in cellular processes regulated by calcium-dependent membrane interactions.
Copine 1 inhibitors typically function by binding to specific domains or sites on the copine 1 protein, hindering its ability to interact with phospholipids in a calcium-dependent manner. This interference can have downstream effects on cellular processes such as vesicle trafficking, membrane fusion, and cytoskeletal rearrangements. The development of copine 1 inhibitors is rooted in the understanding that dysregulation of copine-mediated processes may contribute to various pathological conditions, especially those associated with neuronal dysfunction. Therefore, these inhibitors serve as valuable tools for researchers to dissect the intricate molecular mechanisms involving copine 1 and pave the way for a deeper comprehension of its role in health and disease. As the field of copine 1 research continues to evolve, the exploration of specific inhibitors offers a promising avenue for unraveling the intricacies of cellular signaling and function, providing insights into potential avenues for further investigation and discovery.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $21.00 $65.00 $120.00 $251.00 $815.00 | 23 | |
EGTA can chelate calcium ions, potentially altering calcium-dependent functions of CPNE1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 can inhibit PI3K, which may alter membrane trafficking and signaling processes involving CPNE1. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil can block voltage-dependent calcium channels, potentially impacting CPNE1's calcium-dependent activities. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 can inhibit protein kinase C, which may affect downstream signaling pathways of CPNE1. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W7 can antagonize calmodulin, which may influence CPNE1 activities, given its calcium-dependent nature. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin filaments, potentially affecting CPNE1's role in membrane dynamics or cell signaling. | ||||||
PIK-93 | 593960-11-3 | sc-364588 | 5 mg | $255.00 | ||
PIK93 can inhibit phosphatidylinositol 4-kinase, potentially influencing CPNE1's role in membrane trafficking. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin binds to phosphatidylinositol, potentially affecting its availability for CPNE1's phospholipid-binding activities. | ||||||
ET-18-OCH3 | 77286-66-9 | sc-201021 sc-201021A sc-201021B sc-201021C sc-201021F | 5 mg 25 mg 50 mg 100 mg 1 g | $111.00 $436.00 $843.00 $1576.00 $3756.00 | 6 | |
Edelfosine inhibits phospholipase C, potentially affecting the phospholipid metabolism and signaling pathways involving CPNE1. | ||||||